Repligen

At a glance

Repligen reported 2025 revenue of $738.3M, up 16.4% from $634.4M in 2024. Over 4 years since 2021 ($670.5M), that is growth of about 2.4% a year. Operating margin was 7.5%, down from 24.9% in 2021. Revenue peaked in 2022 at $801.5M. The company posted a loss in 2024.

In the last 12 months 5 insiders reported 0 open-market purchases and 13 sales ($15.3M). 10 of the sales were made under pre-arranged 10b5-1 plans. The largest was a sale of $3.9M by Director Anthony Hunt on Nov 13, 2025.

Repligen filed 11 current reports (Form 8-K) in the last 12 months, most often for results of operations (5), officer or director change (2), unregistered equity sale (1) and acquisition or disposal completed (1). The latest officer or director change was reported on Sep 15, 2026. It reported a material agreement or a completed acquisition or disposal 2 times.

1 of the 20 investors tracked here held Repligen at the last quarter end, worth $11K combined. It is the largest weight for Duquesne Family Office (0.2% of its portfolio). New this quarter: Duquesne Family Office.

Annual results

Fiscal year ends Dec 31 · incorporated in DE

Tracked investors holding (13F)

Weight is the share of each investor's portfolio, as of the quarter end.